1st Quarter - Report

CAPITOL HILL CONSULTING GROUP for PURDUE PHARMA LLP

Firm
Client
Income
$32,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

General Medicare and Medicaid issues including, but not limited to, coverage and reimbursement

LobbyistCovered position, as disclosed
BILL K BREWSTER —
AMY SHANK 2001-2002 Ofc. of Asst. GOP Leader Don Nickles
DAVID THOMPSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

General health care issues related to pharmaceutical and biological products; Federal Food, Drug and Cosmetic Act (21 USC 9); drug safety

LobbyistCovered position, as disclosed
BILL K BREWSTER —
AMY SHANK 2001-2002 Ofc. of Asst. GOP Leader Don Nickles
DAVID THOMPSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act (H.R. 1316)

LobbyistCovered position, as disclosed
BILL K BREWSTER —
AMY SHANK 2001-2002 Ofc. of Asst. GOP Leader Don Nickles
DAVID THOMPSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1316 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.